Utilization of Alpha-1 Anti-trypsin (A1AT) in Infectious Disease Monitoring and Treatment

Journal Title: Journal of Microbiology and Infectious Diseases - Year 2019, Vol 9, Issue 1

Abstract

Alpha one anti-trypsin (A1AT) is a major serine protease inhibitor found circulating in human blood. A1AT related studies mainly focus on A1AT potential biomarker as well as therapeutic target in non-infectious diseases. Their findings indicate A1AT beneficial features may also be applied for monitoring and treating infectious disease. However, only a few studies have reviewed A1AT’s useful properties as a biomarker and therapeutic agent for infectious diseases. This narrative review aims to summarize growing evidences that support the idea of utilizing A1AT as a tool for monitoring and therapy for infectious diseases. A1AT showed potential as a biomarker for a wide spectrum of infectious disease, from virus, bacteria, to parasite. Its level and functionality were proposed to predict risk for disease susceptibility or progression and to indicate response therapy. As promising therapeutic agent in various infectious diseases, the administration of A1AT has shown antimicrobial activity, immunomodulatory and anti-apoptotic effect, in addition to more familiar function, suppressing excessive proteolysis. The broad utilization of A1AT, both as biomarker and therapeutic agent, in studies on infectious diseases seems promising. However, there are issues need to be investigated further before establishing its feasibility as a monitoring and therapy tool against infection diseases. J Microbiol Infect Dis 2019; 9(1): 51-58.

Authors and Affiliations

Irene L. Indalao, Agustiningsih Agustiningsih, Eka Pratiwi, Kartika Dewi Puspa, Hartanti Dian Ikawati, Ririn Ramadhany

Keywords

Related Articles

Helicobacter pylori Stool Antigen Feco-prevalence in Food Workers in Van, Turkey

Objectives: Helicobacter pylori contributes to the pathogenesis of peptic ulcers, cancer, and may also cause extra gastric infections. These bacteria can be transmitted by means of fecal-oral, oral-oral, and gastro-oral...

 Nijerya’da Kızamık Mortalite ve Morbiditesinin Eğilimi: Lagos Eyaletinde 10-Yıllık Hastaneye Dayalı Retrospektif Bir Çalışma

 Amaç: Bu hastaneye dayalı retrospektif kohort çalışma Nijerya’nın Lagos Eyaletinde kızamığın epidemiyolojik eğilimini göstermek amacıyla yapıldı. Yöntemler: Lagos Eyaletinde referans hastane konumundaki dokuz...

Nosocomial Infections in Very Low Birth Weight Infants: Etiology and Risk Factors

Objective: We aimed to find out the incidence and risk factors of nosocomial infections in VLBW neonates and to explore the microbiologic flora, sensitivity pattern and outcome. Methods: A prospective, observational stud...

Bombay’da bir üçüncü basamak hastanede Karbapenem dirençli Enterobacteriaceae sıklığı

Amaç: Karbapenem dirençli Enterobacteriaceae (CRE) enfeksiyonlarındaki artış halk sağlığı için önemli bir tehdit oluşturmaktadır çünkü bu bakterilerin enfeksiyonlarında kullanılabilecek sınırlı sayıda antibiyotik vardır...

Nokardiyoz Epidemiyolojisi – Kuzey Hindistan’dan Altı Yıllık Bir Çalışma

Amaç: Klinik örneklerden yeni Nocardia türlerini izole etmek ve bunların farklı antibiyotiklere olan duyarlılık paternlerini çalışmak. Nokardiyoza eşlik eden değişik risk faktörleri de çalışıldı. Metotlar: Yatan hasta v...

Download PDF file
  • EP ID EP652145
  • DOI 10.5799/jmid.537178
  • Views 128
  • Downloads 0

How To Cite

Irene L. Indalao, Agustiningsih Agustiningsih, Eka Pratiwi, Kartika Dewi Puspa, Hartanti Dian Ikawati, Ririn Ramadhany (2019). Utilization of Alpha-1 Anti-trypsin (A1AT) in Infectious Disease Monitoring and Treatment. Journal of Microbiology and Infectious Diseases, 9(1), 51-58. https://europub.co.uk/articles/-A-652145